Human Milk Fortifiers and Acid-Base Status
Primary Purpose
Premature Birth
Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
changing of fortifier
Sponsored by

About this trial
This is an interventional treatment trial for Premature Birth focused on measuring growth, oral feeding, nutrition
Eligibility Criteria
Inclusion Criteria: growing premature infants with a birth weight < 2000g Exclusion Criteria: congenital malformation chromosomal disorders sepsis metabolic disorders need for mechanical ventilation
Sites / Locations
- University HospitalRecruiting
Outcomes
Primary Outcome Measures
frequency of metabolic acidosis
Secondary Outcome Measures
need for oral bicarbonate administartion
longitudinal growth
weight gain
amino acid levels in plasma an urine
Full Information
NCT ID
NCT00196482
First Posted
September 13, 2005
Last Updated
September 11, 2006
Sponsor
University Medicine Greifswald
Collaborators
NUMICO,Dr. Heike Mueller, Friedrichsdorf, Germany
1. Study Identification
Unique Protocol Identification Number
NCT00196482
Brief Title
Human Milk Fortifiers and Acid-Base Status
Official Title
Impact of Human Milk Fortifiers on Acid-Base Status in Preterm Infants
Study Type
Interventional
2. Study Status
Record Verification Date
September 2005
Overall Recruitment Status
Unknown status
Study Start Date
June 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
February 2006 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
University Medicine Greifswald
Collaborators
NUMICO,Dr. Heike Mueller, Friedrichsdorf, Germany
4. Oversight
5. Study Description
Brief Summary
Double-blind randomized controlled trial to investigate the impact of two human milk fortifiers on acid-base status and longitudinal growth and weight gain in preterm infants.
Two different compositions are tested, main difference is in electrolyte composiiton.
Detailed Description
Two groups each consisting of 15 infants with a birth weight below 2000g are studied.randomization is startified by three birth weigth classes (<1000g, 1000-1500g,1500 - 2000g) human milk fortifier is introduced in two steps after oral feeding is achieved. two acid-base status and electrolyte concentrations are measured. when metabolic acidosis, defined as BE < -6 mmol/l, occurs fortifier feeding is stopped, and after a wash-out period of three days the alternative product is used.again, occurence of metabolic acidosis, need for oral bicarbonate and effect on longitudinal growth an weight gain are registered.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Premature Birth
Keywords
growth, oral feeding, nutrition
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Double
Allocation
Randomized
Enrollment
30 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
changing of fortifier
Primary Outcome Measure Information:
Title
frequency of metabolic acidosis
Secondary Outcome Measure Information:
Title
need for oral bicarbonate administartion
Title
longitudinal growth
Title
weight gain
Title
amino acid levels in plasma an urine
10. Eligibility
Sex
All
Minimum Age & Unit of Time
10 Days
Maximum Age & Unit of Time
3 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
growing premature infants with a birth weight < 2000g
Exclusion Criteria:
congenital malformation chromosomal disorders sepsis metabolic disorders need for mechanical ventilation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Christoph Fusch, Professor
Phone
+49-3834-86-
Ext
6420
Email
fusch@uni-greifswald.de
First Name & Middle Initial & Last Name or Official Title & Degree
Jens Rochow, MD
Phone
+49-3834-86-
Ext
6427
Email
rochow@uni-greifswald.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christoph Fusch
Organizational Affiliation
Department of Neonatology, University Hospital Greifswald
Official's Role
Study Chair
Facility Information:
Facility Name
University Hospital
City
Greifswald
State/Province
M-V
ZIP/Postal Code
17485
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christoph Fusch, Prof. Dr.
First Name & Middle Initial & Last Name & Degree
Jens Rochow, MD
First Name & Middle Initial & Last Name & Degree
Helmut Kuester, MD
12. IPD Sharing Statement
Citations:
PubMed Identifier
33006765
Citation
Amari S, Shahrook S, Namba F, Ota E, Mori R. Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates. Cochrane Database Syst Rev. 2020 Oct 2;10(10):CD012273. doi: 10.1002/14651858.CD012273.pub2.
Results Reference
derived
Learn more about this trial
Human Milk Fortifiers and Acid-Base Status
We'll reach out to this number within 24 hrs